Best Medical Oncologists for Targeted Therapy in Delhi NCR, India

Head and neck cancer refers to a diverse group of malignant tumours arising from the mucosal surfaces, glands, or other tissues of the head and neck region, most commonly squamous cell carcinomas of the oral cavity, pharynx, or larynx. The term encompasses several distinct cancer types that differ in location, behaviour, and treatment approach.

Common warning signs include a persistent sore throat or hoarseness, a non-healing mouth ulcer or red/white patch, difficulty or pain when swallowing, a lump in the neck, unexplained ear pain, nasal obstruction, or unintentional weight loss. Symptoms may vary considerably depending on the tumour's site—for example, voice changes are more typical of laryngeal involvement, while a painless neck mass may suggest lymph node spread from an oropharyngeal primary. It is important to note that these symptoms can also be caused by non-cancerous conditions, so the presence of any one of them does not establish a diagnosis and must be evaluated by a qualified clinician.

Diagnosis typically begins with a detailed history and thorough head and neck examination, including flexible nasopharyngoscopy or laryngoscopy to visualise mucosal surfaces directly. A tissue biopsy—obtained endoscopically, via fine-needle aspiration of a neck mass, or through open biopsy—is essential for histological confirmation and to determine tumour type and grade. Staging is then established using cross-sectional imaging (CT and/or MRI of the head, neck, and chest), and in many cases PET-CT scanning, following the AJCC TNM classification system (stages I–IV), with HPV/p16 status increasingly tested for oropharyngeal tumours because it significantly influences prognosis and treatment planning.

The appropriate treatment strategy depends on tumour site, histological type, TNM stage, HPV status, and the patient's overall health, and is best determined through a multidisciplinary tumour board involving oncology, surgery, and radiation specialists. Early-stage cancers (stages I–II) may be managed with a single modality—either surgery or radiotherapy—while locally advanced disease (stages III–IV) typically requires combined approaches such as concurrent chemoradiotherapy, with or without surgery. For eligible patients, systemic therapies including chemotherapy, immunotherapy (e.g., checkpoint inhibitors such as pembrolizumab), and targeted therapy (e.g., cetuximab) play important roles, particularly in the recurrent or metastatic setting; the optimal regimen is always individualised based on clinical assessment.

Non-surgical pathways are well-established and widely used in head and neck cancer management. Definitive (curative-intent) chemoradiotherapy is a standard of care for many oropharyngeal, laryngeal, and hypopharyngeal cancers, and can preserve organ function while achieving disease control comparable to surgery in appropriately selected patients. Systemic agents—chemotherapy, immunotherapy, and targeted therapy—are central to treatment of recurrent or metastatic disease, and surveillance-only management may be appropriate in select, very early low-risk lesions after discussion with a specialist.

Targeted Therapy may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.

Head and neck cancers are managed by a multidisciplinary team typically led or co-led by a head and neck surgical oncologist (or otolaryngologist–head and neck surgeon), a radiation oncologist, and a medical oncologist with expertise in head and neck malignancies. Additional input from speech and language therapists, dietitians, and reconstructive surgeons is often integral to comprehensive care.

When selecting a care team, look for specialists who practice within a dedicated head and neck oncology multidisciplinary unit, with documented experience in your specific tumour site, access to advanced endoscopic and robotic surgical platforms or intensity-modulated radiotherapy (IMRT) where relevant, and a clear pathway for rehabilitation, nutritional support, and long-term follow-up. Asking about the team's annual case volume for your tumour type and their approach to HPV testing and tumour board review can help you compare providers meaningfully.

Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.

Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.